av/vaxcyte--big.svg

NASDAQ:PCVX

Vaxcyte, Inc.

  • Stock

USD

Last Close

68.50

28/03 20:00

Market Cap

6.12B

Beta: 0.96

Volume Today

674.97K

Avg: 962.38K

PE Ratio

−25.01

PFCF: −32.24

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Select
  • website

    vaxcyte.com
  • ipo date

    Jun 12, 2020
  • full time employees

    158
  • currency

    USD

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pn...Show More

Earnings

Earnings per Share (Estimate*)

-1.5-1-0.52019-03-312020-08-122021-08-112022-11-072024-02-26

Revenue (Estimate*)

0.000.000.010.010.012019-03-312020-08-122021-08-112022-11-072024-02-26

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.